DVAX) Stock? – Share register


Dynavax Technologies Corporation (NASDAQ: DVAX) traded at $ 16.40 last check on Monday November 08, made a 1.49% bullish move from its price the previous day.

Looking at the stock, we see that its previous close was $ 16.16 and the beta (5 years per month) is 1.24 with the price range for the day being $ 14.90 to 18.63. $. In terms of the 52 week price range, DVAX has a high of $ 21.39 and a low of $ 3.79. The company’s shares have lost around -10.92% in the past 30 days.

3 tiny actions ready to explode The world’s largest investor, Warren Buffett, has a simple formula for making big money in the markets. He buys valuable goods when they are very cheap. For stock investors, that means buying cheap small cap stocks like these with huge upside potential.

We have implemented an early warning service to help savvy investors take full advantage of small cap stocks designed for big returns.

Click here for full details and to register for free


Dynavax Technologies Corporation has a market capitalization of $ 2.38 billion and is expected to release its quarterly earnings report on November 4, 2021. Analyst estimates give the company expected earnings per share (EPS) of $ 0.52, with EPS growth for the year increased to $ 0.46 for 2021 and $ 1.19 for next year. These figures represent respectively 161.30% and 158.70% of EPS growth over the two years.

Analysts who track the company’s growth have also given it consensus growth in revenue estimated at $ 196.89 million, with a low of $ 167.68 million and a high of $ 220.9 million. The median projection represents free-fall growth of 907.10% from sales growth for the corresponding quarter a year ago. According to analyst consensus estimates, the company’s annual revenue forecast for 2021 is expected to reach $ 405.88 million, up 771.90 percent from figures released last year.

There have been 2 upward revisions and no downward revisions to the stock’s EPS in the past 7 days, reflecting the nature of the company’s price movement in the short term. On the other hand, looking at the outlook for the DVAX stock, the short-term indicators assign the stock an average of 50% buy, while the medium-term indicators give it an average of 50% buy. Long-term metrics average the stock in the 100% Buy category.

Based on estimates from 4 analysts, where the scores ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 rated Dynavax Technologies Corporation (DVAX) stock as blocked, while 4 l ‘pricing as a purchase. 0 analyst (s) rate it as overweight while 0 of them rate it as underweight, while 0 suggests the stock as a sell. The stock has an overall Buy rating and investors could take advantage of this and get back shares of the company.

Looking further, we notice that the current price point is -12.43% from its SMA20 and -8.55% from its 50-day simple moving average. The RSI (14) peaks at 39.98 while volatility over the past week is 8.85% and climbs to 6.77% over the past month. The beta value is 1.35, while the Average True Range (ATR) currently points to 1.48. The average price target for the stock over the next 12 months is $ 26.00, with estimates having a low of $ 23.00 and a high of $ 30.00. These prices end at -40.24% and -82.93% respectively from the current price level, although investors may be excited about the prospect of -52.44% if the stock price DVAX hits the median price of $ 25.00.

Let’s briefly compare the shares of Dynavax Technologies Corporation (DVAX) to its peers. We see that today’s price change of 1.49% and 291.28% over the last 12 months for DVAX is competing with that of AstraZeneca PLC (AZN), which has seen its price of stock market increase by 1.07% during the last trading session and by 14.38% during the last. year. Another peer Biogen Inc. (BIIB) fell -2.03% today, and was -21.64% in the past year, while Pfizer Inc. (PFE) is also down of -1.49% for the moment, while its price remains in the green. at 40.95% over the same period. Unlike these companies, the S&P 500 Index and the Dow Jones Industrial are now at 0.13% and 0.37%, respectively, in early trades.

Coming back to Dynavax Technologies Corporation (NASDAQ: DVAX), we note that the 3-month average trading volume was 5.00 million. The current shares outstanding are 147.43 million.

>> 7 top choices for the post-pandemic economy

Insiders own 0.10% of the company’s shares while institutions hold 76.90%. Investors should be excited about this stock as it has significant upside potential, with today’s price pushing the stock up 263.15% in the price movement since the start of the year.

Leave A Reply

Your email address will not be published.